The $43.7m ME Innovation Fund is part of a $100m corporate venturing initiative revealed by the electrical product provider in mid-2020 and will invest in digital and green energy companies.

Synthetic DNA producer DNA Script and personalised health plan provider Transcarent each closed $200m corporate-backed series C rounds.

SoftBank's Latin America Fund took part in the construction materials marketplace’s latest round at a reported valuation of $800m.

SoftBank’s Vision Fund 2 co-led the seafood farming technology provider's latest round, which also featured Go-Ventures, as Indonesia's aquaculture technology space begins to look outwards.

Country Garden Venture Capital returned to reinvest in Bluepha having led the the bioplastics developer’s series B2 round five months ago.

Raw materials provider Vital Thin Film secured $188m in a round co-led by BYD while drug developers CinCor and Vigil raised a total of $292m in their initial public offerings.

Harel contributed to drug discovery technology developer Eikon Therapeutics' $518m series B round while a host of corporates are set to exit data management software provider Trifacta in a $400m acquisition.

As animal-free dairy alternatives become more popular, Hochland and Tnuva both took part in the vegan dairy technology developer's latest round.

The digital transformation that has disrupted and reshaped the industrial sector in recent years, known as the fourth industrial revolution or industry 4.0, has now reached a new chapter with the development of what has been dubbed as industry 5.0.

Data software provider Weka raised $73m in a round led by Hitachi Ventures while Advance Publications exited social impact technology developer EverFi in a $750m acquisition.